A detailed history of Financial Gravity Asset Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 39,067 shares of NVS stock, worth $4.07 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
39,067
Previous 33,965 15.02%
Holding current value
$4.07 Million
Previous $3.43 Billion 21.27%
% of portfolio
1.04%
Previous 0.96%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$92.57 - $107.37 $472,292 - $547,801
5,102 Added 15.02%
39,067 $4.16 Billion
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $3.45 Million - $3.93 Million
36,200 Added 82272.73%
36,244 $3.51 Billion
Q4 2023

Jun 26, 2024

SELL
$92.27 - $101.54 $210,283 - $231,409
-2,279 Reduced 6.29%
33,965 $3.43 Billion
Q3 2023

Nov 15, 2023

SELL
$94.73 - $105.13 $5,399 - $5,992
-57 Reduced 56.44%
44 $4,000
Q2 2023

Aug 08, 2023

BUY
$92.52 - $104.91 $832 - $944
9 Added 9.78%
101 $11.5 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $80 - $92
1 Added 1.1%
92 $4.84 Million
Q4 2022

Feb 15, 2023

SELL
$75.55 - $92.52 $125,186 - $153,305
-1,657 Reduced 94.79%
91 $10.8 Million
Q3 2022

Nov 03, 2022

SELL
$74.61 - $87.26 $34,469 - $40,314
-462 Reduced 20.9%
1,748 $4.68 Million
Q2 2022

Aug 05, 2022

SELL
$80.52 - $93.75 $6,280 - $7,312
-78 Reduced 3.41%
2,210 $7.56 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $134,504 - $152,150
1,679 Added 275.7%
2,288 $7.32 Million
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $48,537 - $53,671
609 New
609 $29,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $0 - $0
0 New
0 $82,000
Q2 2021

Aug 11, 2021

BUY
$85.24 - $94.15 $0 - $0
0 New
0 $91,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $1,586 - $1,870
-19 Closed
0 $39,000
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $1,483 - $1,794
19 New
19 $1,000
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $9,145 - $10,294
-113 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$70.67 - $99.01 $3,392 - $4,752
48 Added 73.85%
113 $9,000
Q4 2019

Feb 28, 2020

SELL
$84.35 - $95.37 $1,940 - $2,193
-23 Reduced 26.14%
65 $95,000
Q3 2019

Oct 15, 2019

SELL
$85.54 - $94.26 $6,158 - $6,786
-72 Reduced 45.0%
88 $8,000
Q2 2019

Jul 26, 2019

SELL
$75.4 - $92.8 $13,798 - $16,982
-183 Reduced 53.35%
160 $15,000
Q1 2019

Apr 19, 2019

BUY
$75.32 - $86.15 $13,331 - $15,248
177 Added 106.63%
343 $33,000
Q3 2018

Oct 31, 2018

BUY
$66.94 - $77.43 $736 - $851
11 Added 7.1%
166 $14,000
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $129 - $146
2 Added 1.31%
155 $13,000
Q1 2018

May 23, 2018

BUY
$70.39 - $84.15 $10,769 - $12,874
153 New
153 $12,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.